如何掌握冠状动脉介入治疗术后质子泵抑制剂的应用  

How to Streamline Application of Proton Pump Inhibitors (PPIs) after Percutaneous Coronary Intervention Therapy

作　　者：王贵松[1] 

机构地区：[1]北京大学第三医院心内科

出　　处：《中国处方药》2009年第10期38-39,共2页Journal of China Prescription Drug

摘　　要：最近有关同时应用PPI因降低氯吡格雷抗血小板活性而增加ACS患者再住院率和死亡率的报道引起心血管医师的广泛关注,也引发了人们对PCI术后应用PPI预防上消化道出血作用的重新思考。The recent reports that simultaneous application of PPIs to reduce antiplatelet activity of clopidogrel caused the increasing rehospitalization rates and death rates of the patients with acute coronary syndrome (ACS) attract wide attention of cardiovascular physicians, and cause the rethinking on prevention of upper gastrointestinal bleeding with PPIs after percutaneous coronary intervention (PCI) therapy.

关 键 词：冠状动脉介入治疗术 质子泵抑制剂 抗血小板活性 再住院率 氯吡格雷 出血作用 上消化道 术后应用 

分 类 号：R541.4[医药卫生—心血管疾病]